Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Briefings in Bioinformatics|January 17, 2024
Unsupervised and supervised AI on molecular dynamics simulations reveals complex characteristics of HLA-A2-peptide immunogenicityJeffrey K Weber, Joseph A Morrone, Seung-Gu Kang, et al.Immunity|January 31, 2023
The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colonLingjia Kong, Vladislav Pokatayev, Ariel Lefkovith, et al.Nature Immunology|February 5, 2025
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammationStanislav Dikiy, Aazam P Ghelani, Andrew G Levine, et al.Science Immunology|April 8, 2022
Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunityBriana G Nixon, Chun Chou, Chirag Krishna, et al.Annals of the Rheumatic Diseases|October 4, 2025
Innate immune cell subsets are enriched in synovial fluid of ACPA-negative rheumatoid arthritis and characterized by distinct type I IFN gene signaturesAlexandra Argyriou, Marc H Wadsworth, Joshua Fienman, et al.Transplantation and Cellular Therapy|December 15, 2025
HIGHER HLA-DRB1 EVOLUTIONARY DIVERGENCE (HED) IS ASSOCIATED WITH REDUCED RELAPSE AND IMPROVED SURVIVAL AFTER MATCHED UNRELATED HEMATOPOIETIC CELL TRANSPLANTATIONJennifer N Saultz, Yung-Tsi Bolon, Tao Wang, et al.Cell Reports|March 15, 2024
Translational genetics identifies a phosphorylation switch in CARD9 required for innate inflammatory responsesMarta Brandt, Zhifang Cao, Chirag Krishna, et al.Nature Immunology|May 26, 2022
Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignanciesEmily R Kansler, Saïda Dadi, Chirag Krishna, et al.Science (New York, N.Y.)|February 22, 2024
An immunogenetic basis for lung cancer riskChirag Krishna, Anniina Tervi, Miriam Saffern, et al.Nature Medicine|September 30, 2024
Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumabTyler J Alban, Nadeem Riaz, Prerana Parthasarathy, et al.Pageof 4